FindTrial
Sign In

Investigation of expression of JL1 antigen in acute leukemia or myelodysplastic syndrome

Investigation of expression of JL1 antigen in acute leukemia or myelodysplastic syndrome

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0002236
Enrollment
400
Registered
2017-02-21
Start date
2014-03-13
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Dinona
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Adult of 19 years or older 2. Histologically confirmed acute leukemia or myelodysplastic syndrome 3. Patient whose informed consent is signed by him/herself or legal representative

Exclusion criteria

Exclusion criteria: 1. Patient or legal representative refuses to participate in this study. 2. Additional collection of bone marrow sample for JL1 antigen expression study is needed.

Design outcomes

Primary

MeasureTime frame
Treatment response;Survival duration—

Countries

Korea, Republic of

Contacts

Public ContactJe-Hwan Lee

Asan Medical Center

jhlee3@amc.seoul.kr+82-2-3010-3218

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026